Anyone with common sense dealing with this sector
Post# of 72440
It just doesn't happen.
Brilacidin may hold SOME potential to make the curve but we need to see the trial that moves us into the competition.
Protocol and peer review. That's where the excitement begins imo.
http://www.ipharminc.com/email-alerts